Clinical Trial Update: Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial comparing infusion of umbilical cord-derived versus bone marrow-derived mesenchymal stem cells for cytokine suppression in endothelia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Inflammation
• Metabolic Syndrome

Drugs mentioned

• Bone marrow-derived mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)
• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Joshua M Hare | Conditions: Endothelial Dysfunction, Metabolic Syndrome | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-11-08